Skip to main content

Hologic to acquire Finnish PCR test maker for $795M

The Marlborough-based women's health medical technology company plans to acquire a privately held Finnish developer of molecular diagnostic tests and instrumentation for $795 million.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.